Biotech Updates

"Global Health or Global Wealth?"

September 16, 2010

The McLaughlin-Rotman Centre (MRC) for Global Health reports the findings of MRC researchers Rahim Rezale and Peter A. Singer based at University Health Network and University of Toronto on the choice of domestic health biotech entrepreneurs to contribute to global health or to global wealth. The document is based on the previous report that these domestic health biotech entrepreneurs in the emerging economies of China, India, Brazil and South Africa have made profitable businesses, while making significant contributions to addressing local and global health needs through innovation. The authors suggest that developing country firms can pursue both goals in parallel if targeted support mechanisms are instituted, and they give examples of these.

The document can be downloaded at